| Key Financial Ratios of IOL Chemicals and Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
3.44 |
23.07 |
23.84 |
28.22 |
76.21 |
|
| Diluted EPS (Rs.) |
3.44 |
23.07 |
23.84 |
28.22 |
76.21 |
|
| Cash EPS (Rs.) |
5.89 |
33.77 |
31.70 |
35.59 |
82.35 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
57.48 |
274.46 |
256.61 |
236.80 |
214.69 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
57.48 |
274.46 |
256.61 |
236.80 |
214.69 |
|
| Dividend / Share(Rs.) |
0.80 |
5.00 |
4.00 |
4.00 |
6.00 |
|
| Revenue from Operations/Share (Rs.) |
70.83 |
363.28 |
377.64 |
372.00 |
335.03 |
|
| PBDIT/Share (Rs.) |
7.65 |
44.56 |
42.94 |
49.11 |
104.95 |
|
| PBIT/Share (Rs.) |
5.20 |
33.85 |
35.08 |
41.74 |
98.32 |
|
| PBT/Share (Rs.) |
4.70 |
31.11 |
32.28 |
37.96 |
97.32 |
|
| Net Profit/Share (Rs.) |
3.44 |
23.07 |
23.84 |
28.22 |
75.72 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
10.80 |
12.26 |
11.37 |
13.20 |
31.32 |
|
| PBIT Margin (%) |
7.34 |
9.31 |
9.28 |
11.22 |
29.34 |
|
| PBT Margin (%) |
6.63 |
8.56 |
8.54 |
10.20 |
29.04 |
|
| Net Profit Margin (%) |
4.85 |
6.34 |
6.31 |
7.58 |
22.60 |
|
| Return on Networth / Equity (%) |
5.98 |
8.40 |
9.29 |
11.91 |
35.27 |
|
| Return on Capital Employed (%) |
8.61 |
11.80 |
13.16 |
16.93 |
43.74 |
|
| Return on Assets (%) |
4.24 |
6.03 |
6.92 |
8.45 |
27.61 |
|
| Total Debt/Equity (X) |
0.07 |
0.02 |
0.05 |
0.03 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.90 |
1.00 |
1.11 |
1.22 |
122.16 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.89 |
2.00 |
2.02 |
2.10 |
3.52 |
|
| Quick Ratio (X) |
1.30 |
1.24 |
1.30 |
1.30 |
2.50 |
|
| Inventory Turnover Ratio (X) |
5.29 |
3.82 |
4.18 |
4.48 |
6.66 |
|
| Dividend Payout Ratio (NP) (%) |
23.24 |
21.67 |
16.78 |
21.26 |
5.28 |
|
| Dividend Payout Ratio (CP) (%) |
13.57 |
14.80 |
12.62 |
16.85 |
4.85 |
|
| Earnings Retention Ratio (%) |
76.76 |
78.33 |
83.22 |
78.74 |
94.72 |
|
| Cash Earnings Retention Ratio (%) |
86.43 |
85.20 |
87.38 |
83.15 |
95.15 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,705.63 |
2,012.51 |
1,719.64 |
1,982.03 |
2,867.83 |
|
| EV/Net Operating Revenue (X) |
0.82 |
0.94 |
0.78 |
0.91 |
1.46 |
|
| EV/EBITDA (X) |
7.60 |
7.69 |
6.82 |
6.87 |
4.65 |
|
| MarketCap/Net Operating Revenue (X) |
0.86 |
1.00 |
0.75 |
0.95 |
1.64 |
|
| Retention Ratios (%) |
76.75 |
78.32 |
83.21 |
78.73 |
94.71 |
|
| Price/BV (X) |
1.06 |
1.32 |
1.10 |
1.49 |
2.56 |
|
| Price/Net Operating Revenue |
0.86 |
1.00 |
0.75 |
0.95 |
1.64 |
|
| Earnings Yield |
0.06 |
0.06 |
0.08 |
0.08 |
0.14 |
|
Source : Dion Global Solutions Limited
